Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 20 Feb 2024 for Icosavax, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ann M. Veneman: trading record in brief
Ann M. Veneman, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Alexion Pharmaceuticals Inc and Icosavax, Inc. We count 20 filings; the first trade dates from 28 May 2010 and the latest from 19 February 2024.
No open-market purchase appears, only 8 sales worth €1.4M. Besides market trades, the filings include 8 share grants and 2 option exercises.
The newest entry dates from 20 February 2024: a transaction, in Icosavax, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ann M. Veneman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
11,209 sharesCommon StockSEC:0000950170-24-017423:0
5,543 shares0Common StockSEC:0001209191-22-036748:0
8,500 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-21-031150:0
3 of 3 declarations
